What is the treatment for Group B Streptococcus (GBS) infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Group B Streptococcus (GBS) Infections

Penicillin G is the first-line treatment for Group B Streptococcus infections, with specific alternatives for penicillin-allergic patients based on susceptibility testing. 1, 2

First-Line Treatment Options

Non-Pregnant Adults with GBS Infections

  • Penicillin G: 5 million units IV initially, then 2.5 million units IV every 4 hours until resolution 2
  • Ampicillin: 2 g IV initially, then 1 g IV every 4 hours (acceptable alternative but penicillin G preferred due to narrower spectrum) 3
  • Oral options for less severe infections:
    • Penicillin V: 500 mg four times daily for 10 days
    • Amoxicillin: 500 mg three times daily for 10 days 1

Penicillin-Allergic Patients

  • Low risk of anaphylaxis: Cefazolin 2 g IV initially, then 1 g IV every 8 hours 3, 1
  • High risk of anaphylaxis:
    • Clindamycin 300 mg four times daily for 10 days (only if GBS isolate confirmed susceptible) 1
    • Vancomycin (if GBS isolate resistant to clindamycin or susceptibility unknown) 1

Important: Erythromycin is no longer recommended due to increasing GBS resistance (up to 32.8%) 3, 4

Treatment Based on Infection Type

Invasive GBS Disease

  • Bacteremia/Sepsis: Penicillin G 24 million units/day divided every 4 hours for 10-14 days 2
  • Meningitis:
    • Adults: 24 million units/day as 2 million units every 2 hours 2
    • Children: 250,000 units/kg/day in equal doses every 4 hours for 10-14 days 2
  • Endocarditis: 12-20 million units/day for 4 weeks 2

Urinary Tract Infections

  • First-line: Penicillin or amoxicillin for 10 days 1
  • Alternatives: Amoxicillin-clavulanic acid, nitrofurantoin, or sulfamethoxazole-trimethoprim (consider local resistance patterns) 1

Special Populations

Pregnant Women

  • GBS bacteriuria during pregnancy: Requires treatment at time of diagnosis AND intrapartum antibiotic prophylaxis during labor 1, 5
  • Intrapartum prophylaxis regimen:
    • Penicillin G: 5 million units IV initial dose, then 2.5-3.0 million units IV every 4 hours until delivery 1
    • Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours until delivery 1

Neonates and Infants

  • Early-onset disease: Ampicillin with an aminoglycoside for infants up to 7 days of age 3
  • Late-onset disease: Evaluation should include blood, urine, and cerebrospinal fluid cultures; cerebrospinal fluid analysis; and inflammatory markers 3
  • Dosing for serious infections: 150,000-300,000 units/kg/day of penicillin G divided in equal doses every 4-6 hours 2

Monitoring and Follow-up

  • Clearance cultures should be taken 24 hours after completing treatment 1
  • Additional follow-up cultures at 1,3,6, and 12 weeks are recommended to ensure complete eradication 1
  • For most acute infections, treatment should continue for at least 48-72 hours after the patient becomes asymptomatic 2

Antibiotic Resistance Considerations

  • GBS remains universally susceptible to beta-lactam antibiotics, though there have been reports of reduced susceptibility in some countries 6
  • Resistance to second-line antibiotics is increasing:
    • Clindamycin resistance: 12.7% and rising (increased from 10.5% to 15.0%) 4
    • Erythromycin resistance: 25.6% and rising (increased from 15.8% to 32.8%) 4
  • Vancomycin remains effective with only two documented cases of resistance 6

Important Caveats

  • Oral antimicrobial agents should not be used to treat GBS colonization during pregnancy as this is not effective in eliminating carriage or preventing neonatal disease 3
  • When treating GBS infections, ensure adequate duration of therapy (10 days for most infections, longer for endocarditis and other severe infections) 1, 2
  • Consider local antibiotic resistance patterns when selecting therapy, particularly for second-line agents 1

References

Guideline

Treatment of Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antibiotic resistance patterns in invasive group B streptococcal isolates.

Infectious diseases in obstetrics and gynecology, 2008

Research

Group B Streptococcus in Pregnancy.

Obstetrics and gynecology clinics of North America, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.